CXCL12 and breast cancer: It is demonstrated that breast cancer EVs show strong liver tropism rather than kidney tropism on both the microfluidic and animal models and a CXCL12 mediated chemokine gradient that is unique to the liver PMN is responsible for the breast cancer EV organotropism.